Beike at the 2017 Shenzhen International Biotech Leadership Summit and International Biotech & Health Industry EXPO

Beike at the 2017 Shenzhen International Biotech Leadership Summit and International Biotech & Health Industry EXPO

Dr. Hu Xiang attended the opening ceremony of 2017 Shenzhen International Biotech Leadership Summit to discuss the opportunities and challenges of the development of biomedical big data The opening ceremony…

A Tale of Two Spinal Cord Injury Patients

Shenzhen, China –- June 16th, 2006 — Shenzhen Beike Biotechnology Co., Ltd has announced the successful treatment of two spinal cord injury patients with different methods for treatment – one…

Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease

Beike Biotechnology Co., Ltd. today announced that a team led by Dr. Yang Xiaofeng at its collaborating hospital in Shenyang completed a study to assess clinical efficacy, safety, and feasibility…

American Toddler Sees Dramatic Improvement from Beike Biotechnology Stem Cell Treatment

SHENZHEN, China, Aug. 14 /PRNewswire-USNewswire/ — Shenzhen Beike Biotechnology Co., Ltd. (https://www.beikebiotech.com) today announced the successful treatment with umbilical cord stem cells of three-and-a-half-year- old American toddler Lukas Nguyen. At…

Beike Biotechnology Invests in Leading Japanese Regenerative Medicine Co., Biomaster Inc.

SHENZHEN, China, Nov. 4 /PRNewswire-Asia/ — Shenzhen Beike Biotechnology Co. Ltd. (https://www.beikebiotech.com ), China’s leading stem cell research and regenerative medicine company, announced that it has entered into an agreement…

Stem Cell Leader Beike Biotech and China’s Tsinghua University Receive USD $4 Million for Stem Cell

Patients suffering from a range of debilitating illnesses, such as spinal cord injury, cerebral palsy, optic nerve hypoplasia, multiple sclerosis and ataxia stand to benefit from a new laboratory, established…


1 2 8 9